Literature DB >> 10982174

The cost of treating osteoporotic fractures in the United Kingdom female population.

A Johansen, M Stone.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10982174     DOI： 10.1007/s001980070101

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  12 in total

Review 1.  Exercise in the prevention of falls in older people: a systematic literature review examining the rationale and the evidence.

Authors:  N D Carter; P Kannus; K M Khan
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 2.  Osteoporosis and its management.

Authors:  Kenneth E S Poole; Juliet E Compston
Journal:  BMJ       Date:  2006-12-16

Review 3.  The role of DXA bone density scans in the diagnosis and treatment of osteoporosis.

Authors:  Glen M Blake; Ignac Fogelman
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

4.  NICE: Its Influence in Treating Osteoporosis in the UK and beyond.

Authors:  Juliet Compston
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

5.  Modelling the cost effectiveness of interventions for osteoporosis: issues to consider.

Authors:  Matt D Stevenson; Peter L Selby
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

6.  Prescription of resistance training for healthy populations.

Authors:  C J Hass; M S Feigenbaum; B A Franklin
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

7.  Unstable trochanteric fractures in elderly osteoporotic patients: role of primary hemiarthroplasty.

Authors:  Karuppaiah Karthik; Mayilvahanan Natarajan
Journal:  Orthop Surg       Date:  2012-05       Impact factor: 2.071

8.  Growth in childhood predicts hip fracture risk in later life.

Authors:  M K Javaid; J G Eriksson; E Kajantie; T Forsén; C Osmond; D J P Barker; C Cooper
Journal:  Osteoporos Int       Date:  2010-04-09       Impact factor: 4.507

9.  Meta-analysis identifies a MECOM gene as a novel predisposing factor of osteoporotic fracture.

Authors:  Joo-Yeon Hwang; Seung Hun Lee; Min Jin Go; Beom-Jun Kim; Ikuyo Kou; Shiro Ikegawa; Yan Guo; Hong-Wen Deng; Soumya Raychaudhuri; Young Jin Kim; Ji Hee Oh; Youngdoe Kim; Sanghoon Moon; Dong-Joon Kim; Heejo Koo; My-Jung Cha; Min Hye Lee; Ji Young Yun; Hye-Sook Yoo; Young-Ah Kang; Eun-Hee Cho; Sang-Wook Kim; Ki Won Oh; Moo Il Kang; Ho Young Son; Shin-Yoon Kim; Ghi Su Kim; Bok-Ghee Han; Yoon Shin Cho; Myeong-Chan Cho; Jong-Young Lee; Jung-Min Koh
Journal:  J Med Genet       Date:  2013-01-24       Impact factor: 6.318

Review 10.  Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women.

Authors:  J A Kanis; F Borgstrom; O Johnell; B Jonsson
Journal:  Osteoporos Int       Date:  2004-06-03       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.